Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025

Objectives: Fungal infection–associated deaths increased in the United States during the COVID-19 pandemic, but mortality patterns after the pandemic peak are not well-characterized. We analyzed national mortality data to assess whether fungal mortality remained elevated during 2022-2025 and to describe demographic, geographic, pathogen-specific, and underlying cause-of-death patterns after the COVID-19 pandemic peak. Methods: We analyzed National Vital Statistics System multiple-cause-of-death data for 2022-2025. We defined fungal deaths as deaths with a fungal pathogen listed as an underlying or contributing cause of death and summarized deaths by year, month, pathogen, COVID-19 association, underlying cause of death, demographic characteristics, and US Census division. We used 2018-2019 (prepandemic) and 2021 (peak) as reference periods for selected comparisons. Results: During 2022-2025, a total of 30 225 fungal deaths occurred (annual average = 7556). The annual age-adjusted mortality rate per 100 000 population increased from 1.2 in 2018-2019 to 1.5 in 2020 and 1.9 in 2021, and remained between 1.8 and 1.9 during 2022-2025. COVID-19–associated fungal deaths declined after early 2022, but overall fungal mortality remained stable. During 2022-2025, the most common underlying causes of death among fungal deaths were malignant neoplasms, HIV disease, and diseases of the heart; the most commonly specified pathogens were Candida and Aspergillus . Mortality rates varied by age, sex, race and ethnicity, and region. Conclusions: Fungal mortality remained elevated after the COVID-19 pandemic peak despite declines in COVID-19–associated fungal deaths. Continued efforts to monitor fungal disease–related mortality are important to inform efforts to enhance diagnostic capacity and surveillance to better characterize and ultimately reduce the impact of fungal diseases.

Authors

Institutions

Publication Details

Journal
Public Health Reports
Published
2026-11-19
DOI
https://doi.org/10.1177/00333549261502697
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025

Mitsuru Toda, Johnathan A. Edwards, Jodi A. Cisewski, Jeremy A.W. Gold et al.
Public Health Reports
Antifungal resistance and susceptibility
article

Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025

Mitsuru Toda, Johnathan A. Edwards, Jodi A. Cisewski, Jeremy A.W. Gold, Lauren M. Rossen, Farida B. Ahmad, Meagan K. Andrews
article en

Abstract

Objectives: Fungal infection–associated deaths increased in the United States during the COVID-19 pandemic, but mortality patterns after the pandemic peak are not well-characterized. We analyzed national mortality data to assess whether fungal mortality remained elevated during 2022-2025 and to describe demographic, geographic, pathogen-specific, and underlying cause-of-death patterns after the COVID-19 pandemic peak. Methods: We analyzed National Vital Statistics System multiple-cause-of-death data for 2022-2025. We defined fungal deaths as deaths with a fungal pathogen listed as an underlying or contributing cause of death and summarized deaths by year, month, pathogen, COVID-19 association, underlying cause of death, demographic characteristics, and US Census division. We used 2018-2019 (prepandemic) and 2021 (peak) as reference periods for selected comparisons. Results: During 2022-2025, a total of 30 225 fungal deaths occurred (annual average = 7556). The annual age-adjusted mortality rate per 100 000 population increased from 1.2 in 2018-2019 to 1.5 in 2020 and 1.9 in 2021, and remained between 1.8 and 1.9 during 2022-2025. COVID-19–associated fungal deaths declined after early 2022, but overall fungal mortality remained stable. During 2022-2025, the most common underlying causes of death among fungal deaths were malignant neoplasms, HIV disease, and diseases of the heart; the most commonly specified pathogens were Candida and Aspergillus . Mortality rates varied by age, sex, race and ethnicity, and region. Conclusions: Fungal mortality remained elevated after the COVID-19 pandemic peak despite declines in COVID-19–associated fungal deaths. Continued efforts to monitor fungal disease–related mortality are important to inform efforts to enhance diagnostic capacity and surveillance to better characterize and ultimately reduce the impact of fungal diseases.

Public Health Reports
Centers for Disease Control and Prevention (US), National Center for Health Statistics (US), Emory University (US), Stellenbosch University (ZA)
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon